Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2018
[Enhancement of Cytotoxic T Lymphocytes(CTLs)Infiltration into the Cancer Tissues]Yu Akazawa, Toshihiro Suzuki, Tetsuya Nakatsura
Frontiers in Microbiology|July 29, 2020
Batch-Learning Self-Organizing Map Identifies Horizontal Gene Transfer Candidates and Their Origins in Entire GenomesTakashi Abe, Yu Akazawa, Atsushi Toyoda, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 15, 2024
Usefulness of pancreatic volume quantitative analysis as a predictor of development and severity of post-endoscopic retrograde cholangiopancreatography pancreatitisYu Akazawa, Masahiro Ohtani, Takuto Nosaka, et al.
Heliyon|August 7, 2024
Changes of circulating tumor cells expressing CD90 and EpCAM in early-phase of atezolizumab and bevacizumab for hepatocellular carcinomaTakuto Nosaka, Yosuke Murata, Yu Akazawa, et al.
Scientific Reports|April 13, 2019
Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgeryYu Akazawa, Shoichi Mizuno, Norihiro Fujinami, et al.
BMC Gastroenterology|May 22, 2023
High correlation of hepatic shear wave velocity with esophageal varices complication rate in patients with chronic liver diseasesShouichi Namikawa, Takuto Nosaka, Hidetaka Matsuda, et al.
DEN Open|November 6, 2025
Delayed Biliary Hemorrhage due to Pseudoaneurysm Rupture Caused by Migration of Placed Plastic Stent After Endoscopic Ultrasound-Guided HepaticogastrostomyYu Akazawa, Masahiro Ohtani, Yosuke Murata, et al.
Cancers|September 13, 2025
Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab and LenvatinibTakuto Nosaka, Yosuke Murata, Yu Akazawa, et al.
Frontiers in Immunology|August 13, 2025
Risk factors and long-term prognostic impact of immune related pancreatic injury in patients receiving immune checkpoint inhibitorsYu Akazawa, Takuto Nosaka, Yosuke Murata, et al.
Cancer Science|May 12, 2020
Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancerYu Akazawa, Yuki Saito, Toshiaki Yoshikawa, et al.
Pageof 4